Valderrama, Begoña P. http://orcid.org/0000-0003-0175-1263
González-del-Alba, Aránzazu
Morales-Barrera, Rafael
Peláez Fernández, Ignacio
Vázquez, Sergio
Caballero Díaz, Cristina
Domènech, Montserrat
Fernández Calvo, Ovidio
Gómez de Liaño Lista, Alfonso
Arranz Arija, José Ángel
Article History
Accepted: 22 February 2022
First Online: 26 March 2022
Declarations
:
: AGLL reports Advisory Board and Speaker from Roche, Pfizer and Astellas; Speaker from MSD and BMS and Speaker and Other from AstraZecena<b>.</b> BPV reports Advisory Board, Speaker and Other from Astellas, Roche, BMS and Merk-Pfizer; Advisory Board and Other from Ipsen; Advisory Board and Speaker from EUSA and MSD and Advisory Board from Sanofi. IPF report Advisory Board, Speaker and Other from Pfizer; Speaker and Other from Ipsen and Roche; Advisory Board from EUSA and BMS and Speaker from Novartis and MSD<b>.</b> OFC reports Advisory Board and Speaker from Ipsen and Astellas; Advisory Board from BMS and Pfizer-Merck and Speaker from AstraZeneca. AGA has received research funding from Astellas, travel grants from Astellas, Jansen, Sanofi, BMS, Roche, Pfizer and Ipsen and honoraria for speaker engagements, advisory boards and continuous medical education from Janssen, Astellas, Sanofi, Bayer, Roche, Ipsen, BMS, MSD, Pfizer, Eusa Pharma, Eisai and AstraZeneca. JAA reports honoraria from Astellas, Pfizer and BMS; conulting or advisory role from Pfizer, Astellas, Janssen-Cilag, MSD Oncology, BMS, Merck, AstraZeneca, Bayer and Eisai and Research Funding from BMS. RMB, SVE, CCD and MDS have nothing to disclose.